Hepatology

Discover a study revealing how subclinical liver fibrosis, measured by FIB-4, predicts increased mortality risk in coronary artery disease patients.

While other machine learning models like MoRAL-AI and TRAIN-AI have also shown promise, TRIUMPH distinguishes itself through its robust generalisability.

While the primary outcome, a ≥10% reduction in α-SMA, was reached in 29% of ReFerm® recipients versus 14% in the control group, the difference was not statistically significant.

Using superconducting quantum interference device magnetometry, researchers examined the magnetic properties of post-mortem brainstem tissue from four individuals.

Large UK studies show no increased liver cancer risk with oral contraceptives, though longer use may slightly raise risk.

In this study, MASLD was identified in 50% of the T2DM cohort using non-invasive methods, slightly lower than some global estimates.

Discover a study exploring how gut microbiome imbalances contribute to MASLD progression and offer new diagnostic and therapeutic possibilities.

Metabolic and genetic disorders emerged as the most frequent aetiological group, reflecting broader diagnostic capabilities compared to earlier studies.